Jacobs Levy Equity Management
OMIC

Jacobs Levy Equity Management’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Jacobs Levy Equity Management’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11,956
Closed -$137K – 1097
2023
Q3 		$137K Buy
11,956
+5,103
+74% +$94.8K ﹤0.01% 934
2023
Q2 		$171K Buy
+6,853
New +$201K ﹤0.01% 935

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
QM
QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jacobs Levy Equity Management's OMIC Position: Q4 2023 in Review

Jacobs Levy Equity Management sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q4 2023, closing a stake of 11,956 shares — an estimated $137K sold.

Jacobs Levy Equity Management first reported a position in OMIC in Q2 2023 and held it in 2 quarters. The position peaked at $171K in Q2 2023. 47 funds tracked by Wall St. Rank hold OMIC as of Q4 2023.

  • Jacobs Levy Equity Management reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 11,956 Singular Genomics Systems, Inc. Common Stock shares in Q4 2023, an estimated $137K.
  • Jacobs Levy Equity Management first reported a position in Singular Genomics Systems, Inc. Common Stock in Q2 2023 and held it in 2 quarters.
  • Jacobs Levy Equity Management's Singular Genomics Systems, Inc. Common Stock position peaked at $171K in Q2 2023.
  • 47 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q4 2023.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2023, filed 14 Feb 2024.